Literature DB >> 32060675

Smoking cessation and incident dementia in elderly Japanese: the Ohsaki Cohort 2006 Study.

Yukai Lu1, Yumi Sugawara2, Shu Zhang1, Yasutake Tomata1, Ichiro Tsuji1.   

Abstract

To investigate the association of smoking status and years since smoking cessation with the risk of incident dementia among elderly Japanese. We conducted a longitudinal analysis of smoking status and smoking cessation with dementia in prospective cohort study of 12,489 Japanese individuals aged ≥ 65 years who were followed up for 5.7 years. Information on smoking status and other lifestyle factors was collected via a questionnaire in 2006. Data on incident dementia were retrieved from the public Long-term Care Insurance Database. The Cox proportional hazards model was used to estimate the multivariable-adjusted hazard ratios (HRs) and 95% confidence intervals (95% CIs) for incident dementia. During 61,613 person-years of follow-up, 1110 cases (8.9%) of incident dementia were documented. Compared with individuals who had never smoked, current smokers showed a higher risk of dementia (HR 1.46, 95% CI 1.17, 1.80). Among ex-smokers, the risk for those who had stopped smoking for ≤ 2 years was still high (HR 1.39, 95% CI 0.96, 2.01), however, quitting smoking for 3 years or longer mitigated the increased risk incurred by smokers; the multivariable HRs (95% CIs) were 1.03 (0.70, 1.53) for those who had stopped smoking for 3-5 years, 1.04 (0.74, 1.45) for 6-10 years, 1.19 (0.84, 1.69) for 11-15 years, and 0.92 (0.73, 1.15) for > 15 years. Our study suggests that the risk of incident dementia among ex-smokers becomes the same level as that of never smokers if they maintain abstinence from smoking for at least 3 years.

Entities:  

Keywords:  Cohort study; Elderly population; Incident dementia; Smoking; Smoking cessation

Year:  2020        PMID: 32060675     DOI: 10.1007/s10654-020-00612-9

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  7 in total

Review 1.  The Lifelong Health Support 10: a Japanese prescription for a long and healthy life.

Authors:  Ahmed Arafa; Yoshihiro Kokubo; Rena Kashima; Masayuki Teramoto; Yukie Sakai; Saya Nosaka; Youko M Nakao; Emi Watanabe
Journal:  Environ Health Prev Med       Date:  2022       Impact factor: 4.395

2.  Interaction between genetic predisposition, smoking, and dementia risk: a population-based cohort study.

Authors:  Na Zhang; Janice M Ranson; Zhi-Jie Zheng; Eilis Hannon; Zhenwei Zhou; Xuejun Kong; David J Llewellyn; Daniel A King; Jie Huang
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

3.  Ebselen prevents cigarette smoke-induced cognitive dysfunction in mice by preserving hippocampal synaptophysin expression.

Authors:  Simone N De Luca; Kurt Brassington; Stanley M H Chan; Aleksandar Dobric; Kevin Mou; Huei Jiunn Seow; Ross Vlahos
Journal:  J Neuroinflammation       Date:  2022-03-29       Impact factor: 8.322

4.  Risk of Dementia After Smoking Cessation in Patients With Newly Diagnosed Atrial Fibrillation.

Authors:  Hui-Jin Lee; So-Ryoung Lee; Eue-Keun Choi; Sang-Hyun Park; Jae-Wook Chung; Jung-Min Choi; Min-Ju Han; Jin-Hyung Jung; Kyung-Do Han; Seil Oh; Gregory Y H Lip
Journal:  JAMA Netw Open       Date:  2022-06-01

5.  Smoking Status and Cognitive Function in a National Sample of Older Adults.

Authors:  Qiaoyang Zhang; Min Zhang; Yun Chen; Shumin Zhu; Wang Zhou; Lihao Zhang; Guanzhong Dong; Yin Cao
Journal:  Front Psychiatry       Date:  2022-07-06       Impact factor: 5.435

6.  The identification of established modifiable mid-life risk factors for cardiovascular disease which contribute to cognitive decline: Korean Longitudinal Study of Aging (KLoSA).

Authors:  Yebeen Ysabelle Boo; Otto-Emil Jutila; Meghan A Cupp; Logan Manikam; Sung-Il Cho
Journal:  Aging Clin Exp Res       Date:  2021-02-04       Impact factor: 3.636

Review 7.  Smoking and Neuropsychiatric Disease-Associations and Underlying Mechanisms.

Authors:  Omar Hahad; Andreas Daiber; Matthias Michal; Marin Kuntic; Klaus Lieb; Manfred Beutel; Thomas Münzel
Journal:  Int J Mol Sci       Date:  2021-07-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.